Home › Funds › Two Sigma Investments › SLN
Two Sigma Investments position in SLN
SILENCE THERAPEUTICS PLC · Health Care
Latest position (Q2 2026)121.00K sh
Reported value held$1.33M
Portfolio Weight0.00%
First reportedQ1 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 107.21K | $2.32M | New |
| Q2 2024 | 99.11K | $1.88M | Reduce |
| Q3 2024 | 169.39K | $3.08M | Add |
| Q4 2024 | 142.05K | $977.32K | Reduce |
| Q1 2025 | 76.01K | $214.34K | Reduce |
| Q1 2025 | 76.01K | $214.34K | Reduce |
| Q2 2025 | 59.31K | $344.01K | Reduce |
| Q2 2025 | 59.31K | $344.01K | Reduce |
| Q3 2025 | 63.25K | $328.25K | Add |
| Q4 2025 | 39.34K | $239.21K | Reduce |
| Q1 2026 | 16.20K | $85.39K | Reduce |
| Q2 2026 | 121.00K | $1.33M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SLN
- Citadel Advisors 1.33M sh · $14.60M · Q2 2026
- Millennium Management 909.28K sh · $9.98M · Q2 2026
- Balyasny Asset Management 610.98K sh · $6.71M · Q2 2026
- Morgan Stanley 403.17K sh · $4.43M · Q2 2026
- UBS Group AG 243.15K sh · $2.67M · Q2 2026
- BlackRock Inc 219.92K sh · $2.41M · Q2 2026
- Goldman Sachs Group 155.93K sh · $1.71M · Q2 2026
- Marshall Wace 72.04K sh · $790.99K · Q2 2026
- Geode Capital Management 29.54K sh · $324.33K · Q2 2026
- Bank of America Corp 25.28K sh · $277.57K · Q2 2026
- Renaissance Technologies 16.93K sh · $185.89K · Q2 2026